- To describe evolution of cycle duration from baseline to end of treatment by assessing mean cycle duration (in days) at baseline, separately in polymenorrhea, (i.e., cycle duration &lt; 21 days) and oligomenorrhea (i.e., cycle duration &gt; 35 days) groups, and at the end of treatment.